PRIMOLUT N

This brand name is authorized in Australia, Finland, Malta, Nigeria, Netherlands, New Zealand, Singapore, Turkey, United Kingdom

Active ingredients

The drug PRIMOLUT N contains one active pharmaceutical ingredient (API):

1 Norethisterone UNII T18F433X4S - NORETHINDRONE

Norethisterone has progestational actions similar to those of progesterone, but is a more potent inhibitor of ovulation and has weak oestrogenic and androgenic properties. It is used to treat a number of disorders of the menstrual cycle. Read about Norethisterone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PRIMOLUT N Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03DC02	Norethisterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DC Estren derivatives
Discover more medicines within G03DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2993M
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 558718
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 18635
Country: MT	Medicines Authority	Identifier(s): MA639/02501
Country: NG	Registered Drug Product Database	Identifier(s): 04-5063
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 94
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 3347
Country: SG	Health Sciences Authority	Identifier(s): 04403P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699546010066, 8699546015726, 8699546015733